ArticlePLoS medicine2008

Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.

Steffen Borrmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.